HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND SYSTEMIC ARTERIAL HYPERTENSION ARE ASSOCIATED WITH HEPATIC NECROINFLAMMATORY

Gustavo Henrique De Puy E Souza1, Luciana Diniz Silva2,3, Diego Alves Vieira3,4

  • 1Faculdade de Medicina da Universidade Federal de Minas Gerais, Departamento de Patologia e Medicina Legal, Belo Horizonte, MG, Brasil.

PubMed

Insights

Low high-density lipoprotein cholesterol (HDL-C) and hypertension are linked to liver inflammation in chronic hepatitis C (CHC). These factors increase the risk of necroinflammatory activity, impacting liver health in CHC patients.

Area of Science:

  • Hepatology
  • Cardiovascular Disease
  • Clinical Biochemistry

Background:

  • Chronic hepatitis C (CHC) affects millions globally, potentially leading to cirrhosis and liver cancer.
  • CHC is increasingly linked to cardiovascular disease, but underlying mechanisms require clarification.
  • Understanding the interplay between liver histology, comorbidities, and lipid profiles in CHC is crucial.

Purpose of the Study:

  • To investigate associations between hepatic histology and clinical/biochemical parameters in CHC patients.
  • To evaluate the relationship between lipid profiles, comorbidities, and liver disease severity in CHC.
  • To identify predictors of liver fibrosis and necroinflammatory activity in CHC.

Main Methods:

  • Prospective study of 85 CHC outpatients undergoing liver biopsy.
  • Fibrosis staging using the METAVIR system (F0-F4).
  • Activity grading (A0-A3) based on hepatocyte necrosis and inflammation; logistic regression analysis.

Main Results:

  • Older age, steatosis, and low HDL-C (<60 mg/dL) were independently associated with liver fibrosis.
  • Hypertension and low HDL-C (<60 mg/dL) were independently associated with necroinflammatory activity.
  • Elevated triglycerides (≥150 mg/dL) correlated with lobular inflammatory activity.

Conclusions:

  • Low HDL-C levels (<60 mg/dL) are a significant independent predictor of necroinflammatory activity in CHC.
  • Hypertension is associated with an increased risk of developing necroinflammatory activity in CHC patients.
  • Lipid profile and comorbidities significantly influence liver disease progression and activity in CHC.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
681
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
565
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
171
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
98
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
597
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9